Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 19, 2022
Source ID
10.1038/s41386-022-01266-9

Entities

People

  • Alan L. Peterson
  • Alexandar Timchenko
  • Antoinette Brundige
  • Argelio L. López-roca
  • Brenda Martini
  • Brett T Litz
  • Chadi Abdallah
  • Charles E. Bryant
  • Deepak C D'Souza
  • Douglas E Williamson
  • Eric J. Baltutis
  • Ismene L. Petrakis
  • Jim Mintz
  • John D. Roache
  • John Krystal
  • John P. Mccallin Iii
  • Karl A. Lautenschlager
  • Kevin B. Guthmiller
  • Kyung-heup Ahn
  • Lynnette A. Averill
  • Matthew B. Hoch
  • Mohamed A. Sherif
  • Mohini Ranganathan
  • Paulo R. Shiroma
  • Prerana Purohit
  • Ralitza Gueorguieva
  • Rebecca R. Burson
  • Sergio E. Souza
  • Stacey Young-McCaughan
  • Steven M. Southwick
  • Terence M. Keane
  • William Murff

Organizations

  • United States Department of Defense